Cytokinetics (CYTK)

Cytokinetics Stock Forecast & Price Target

See the Price Targets and Ratings of:

Analyst Rating Consensus

Strong Buy
11 Buy
0 Hold
0 Sell
Based on 11 analysts giving stock ratings to
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CYTK Stock Price Prediction

Average Price Target

▲(30.83% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Cytokinetics in the last 3 months. The average price target is $66.45 with a high forecast of $80.00 and a low forecast of $53.00. The average price target represents a 30.83% change from the last price of $50.79.
Highest Price Target$80.00Average Price Target$66.45Lowest Price Target$53.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Upside / Downside
Upgrade Banner
Piper Sandler
Piper says Cytokinetics pullback due to Street 'misunderstanding' financingPiper says Cytokinetics pullback due to Street 'misunderstanding' financing
Goldman Sachs
Cytokinetics (CYTK) Receives a Buy from Goldman Sachs
Cytokinetics (CYTK) PT Raised to $58 at BarclaysBarclays analyst Carter Gould raised the price target on Cytokinetics (NASDAQ: CYTK) to $58.00 (from $52.00) while maintaining a Overweight rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
VTYXVentyx Biosciences
PRVAPrivia Health Group
RXDXPrometheus Biosciences
IMCRImmunocore Holdings
SKINBeauty Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

CYTK Stock Forecast FAQ

What is CYTK’s average 12-month price target, according to analysts?
Based on analyst ratings, Cytokinetics’s 12-month average price target is $66.45.
    What is CYTK’s upside potential, based on the analysts’ average price target?
    Cytokinetics has 30.83% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CYTK a Buy, Sell or Hold?
          Cytokinetics has a conensus rating of Strong Buy which is based on 11 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Cytokinetics’s price target?
            The average price target for Cytokinetics is $66.45. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $80.00 ,the lowest forecast is $53.00. The average price target represents 30.83% Increase from the current price of $50.79.
              What do analysts say about Cytokinetics?
              Cytokinetics’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis